Renal response to arginine vasopressin during the oestrous cycle in the rat: comparison of glucose and saline infusion using physiological doses of vasopressin.
The renal response to arginine vasopressin in the rat has been shown to depend on reproductive status. However there is no consensus as to when the kidney is most responsive. The varying results could depend on the protocol and the dose of hormone used. A study has been performed, with physiological doses of vasopressin, comparing the responses during infusion of hypotonic saline and glucose. After an equilibration period of 150 min, conscious rats were infused on each of the four days of the oestrous cycle with either isotonic saline (0.077 M) or 0.14 M glucose for a control period of 45 min. Vasopressin was then infused at 10-40 fmol min(-1) for 1 h, followed by a recovery period of 90 min. Timed urine samples were collected for determination of volume, sodium concentration and osmolality. During the control period urine flow was greatest at oestrus and dioestrus day 2 and sodium excretion on dioestrus day 2 irrespective of the infusate. Vasopressin concentrations achieved lay within the physiological range and no difference was observed between the different days for a given dose. Infusion of vasopressin in both saline and glucose produced a dose-dependent antidiuresis, the greatest responses being seen of pro-oestrus and dioestrus day 2. It was only with the highest rate of infusion that a significant increase in sodium excretion was seen on each day of the cycle and the greatest responses were seen on pro-oestrus and dioestrus day 1 for both infusates. Thus the kidney shows the greatest response to physiological doses of vasopressin at pro-oestrus and dioestrus day 1 irrespective of the infusate employed.
Hartley
David E
DE
2-38A, Neuroendocrine Laboratories, New Hunt's House, GKT School of Medicine, Guy's Campus, London Bridge, London SE1 1UL, UK.
Forsling
Mary L
ML
D000818:Animals; D001127:Arginine Vasopressin / Q000097:blood / Q000494:pharmacology*; D004231:Diuresis / Q000187:drug effects; D030762:Estrous Cycle / Q000187:drug effects* / Q000502:physiology; D005260:Female; D005947:Glucose / Q000494:pharmacology*; D007038:Hypotonic Solutions / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D012076:Renal Agents / Q000097:blood / Q000494:pharmacology*; D012964:Sodium / Q000493:pharmacokinetics; D012965:Sodium Chloride / Q000494:pharmacology*; D014556:Urine; D014882:Water-Electrolyte Balance / Q000187:drug effects / Q000502:physiology
D007038:Hypotonic Solutions; D012076:Renal Agents; D001127:Arginine Vasopressin; D012965:Sodium Chloride; D012964:Sodium; D005947:Glucose